Urinalysis demonstrated ketonuria
In contrast, GLP-1 receptor agonists are particularly effective in reducing major adverse cardiovascular events, while their effect on HF hospitalization appears more modest, with relative risk reductions of approximately 11% (HR 0.89) in pooled analyses [6, 14]
10.1016/S0140-6736(84)92209-8 Stumpf DA, Parker WD, Haas R: Carnitine deficiency with valproate therapy
The team of Ralf Jockers in collaboration with the team of Dr Amlie Bonnefond from the European Genomic Institute for Diabetes (EGID, Lille, France), the Huazhong University of Science and Technology (Wuhan, China), the Baylor College of Medicine (Houston, USA) and Imperial College Lonodon (UK) performed a large-scale functional genetics analysis of 60 rare GLP1R mutations